Real-World study tracks how long patients stick with gut disease drug
Disease control
Not yet recruiting
This study observes 35 adults with moderate-to-severe Crohn's disease or ulcerative colitis to see how long they continue taking guselkumab in everyday medical practice. Researchers will track treatment persistence and early symptom relief, like reduced bowel urgency. No experime…
Sponsor: Janssen-Cilag Pharma GmbH • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC